Treatment-Shortening Effect of a Novel Regimen Combining High-Dose Rifapentine and Clofazimine in Pathologically Distinct Mouse Models of Tuberculosis
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00388-19
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
American Society for Microbiology